Analysis: Science may have the answers, but more time is needed to crush Covid-19

In normal times, regulators would take at least three months to review clinical trial data, but Covid-19 has fast-tracked the process.
A scientific breakthrough this week raised hope that 50m doses of the first Covid-19 vaccine could be made available before the year is out.
News that Pfizer/BioNtech’s mRNA vaccine could be 90% effective at preventing illness from Covid-19 sent tidal waves of hope around the world. There may be an end in sight.